{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:32:46Z","timestamp":1786649566531,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:p>Autoantibodies are the cause of the chronic inflammatory diseases known as neuromyelitis optica spectrum disorders (NMOSD). Serum antibodies (Abs) that specifically target the aquaporin-4 (AQP-4) water channel are the cause of recurrent episodes of optic neuritis, myelitis, and\/or brain stem disorders. In contrast to AQP-4 Abs, myelin oligodendrocyte glycoprotein (MOG) Abs are detected in some patients exhibiting nonmotor cognitive impairment. These days, the term \u201cMOG-encephalomyelitis\u201d (MOG-EM) is frequently used to describe these clinical syndromes. The diagnosis of these cases involves the use of magnetic resonance imaging, optical coherence tomography, antibody detection, and additional laboratory testing. By detecting the patient\u2019s Abs in their serum or cerebrospinal fluid (CSF), indirect immunofluorescence (IIF) aids in the proper diagnosis. We highlight five NMOSD cases where serum anti-MOG antibody positivity was found using IIF, but CSF was not. In none of the cases, anti-AQP Abs were found. Effective patient management strategies include the treatment of acute attacks and long-term immunosuppressive drugs such as rituximab, azathioprine, and immunoglobulins. IIF is a quick and easy tool to detect anti-MOG Abs in patients with NMOSD\/myelin oligodendrocyte glycoprotein antibody-associated disorder. CSF testing for MOG or AQP-4 Abs is not usually advised. It does not offer additional benefits to help with MOG-EM or NMOSD diagnosis.<\/jats:p>","DOI":"10.4103\/aam.aam_37_24","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T03:00:34Z","timestamp":1723604434000},"page":"731-736","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Indirect Immunofluorescence-Aided Detection of Antimyelin Oligodendrocyte Glycoprotein Antibodies in Neuromyelitis Optica Spectrum Disorder\/Myelin Oligodendrocyte Glycoprotein-Associated Antibody Disorder: A Case Series Involving Five Patients"],"prefix":"10.4103","volume":"23","author":[{"given":"Debamita","family":"Datta","sequence":"first","affiliation":[{"name":"Department of Biochemistry, AIIMS, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mala","family":"Mahto","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, AIIMS, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upasna","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Radiology, AIIMS, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, AIIMS, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"R1-20260427","doi-asserted-by":"crossref","first-page":"12970","DOI":"10.3390\/ijms131012970","article-title":"Molecular pathogenesis of neuromyelitis optica","volume":"13","author":"Bukhari","year":"2012","journal-title":"Int J Mol Sci"},{"key":"R2-20260427","doi-asserted-by":"crossref","first-page":"e965.","DOI":"10.1212\/NXI.0000000000000965","article-title":"Investigating the presence of interattack astrocyte damage in neuromyelitis optica spectrum disorder: Longitudinal analysis of serum glial fibrillary acidic protein","volume":"8","author":"Hyun","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R3-20260427","doi-asserted-by":"crossref","first-page":"396.","DOI":"10.3389\/fneur.2020.00396","article-title":"Value of area postrema syndrome in differentiating adults with AQP4 versus MOG antibodies","volume":"11","author":"Hyun","year":"2020","journal-title":"Front Neurol"},{"key":"R4-20260427","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/ene.13224","article-title":"Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis","volume":"24","author":"Hyun","year":"2017","journal-title":"Eur J Neurol"},{"key":"R5-20260427","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ophtha.2019.04.042","article-title":"Epidemiologic and clinical characteristics of optic neuritis in Japan","volume":"126","author":"Ishikawa","year":"2019","journal-title":"Ophthalmology"},{"key":"R6-20260427","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/08916934.2014.883501","article-title":"A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica","volume":"47","author":"Iyer","year":"2014","journal-title":"Autoimmunity"},{"key":"R7-20260427","doi-asserted-by":"crossref","first-page":"e841.","DOI":"10.1212\/NXI.0000000000000841","article-title":"Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology","volume":"7","author":"Fujihara","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R8-20260427","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3174\/ajnr.A4638","article-title":"Improved lesion detection by using axial T2-weighted MRI with full spinal cord coverage in multiple sclerosis","volume":"37","author":"Galler","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"R9-20260427","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1007\/s00415-020-10024-0","article-title":"Cell-based assays for the detection of MOG antibodies: A comparative study","volume":"267","author":"Gastaldi","year":"2020","journal-title":"J Neurol"},{"key":"R10-20260427","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"R11-20260427","doi-asserted-by":"crossref","first-page":"e1126.","DOI":"10.1212\/NXI.0000000000001126","article-title":"Leveraging visual outcome measures to advance therapy development in neuroimmunologic disorders","volume":"9","author":"Graves","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R12-20260427","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1352458511406165","article-title":"The differential diagnosis of longitudinally extensive transverse myelitis","volume":"18","author":"Kitley","year":"2012","journal-title":"Mult Scler"},{"key":"R13-20260427","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/jnnp-2019-322286","article-title":"CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD","volume":"91","author":"Kleerekooper","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R14-20260427","doi-asserted-by":"crossref","first-page":"e504.","DOI":"10.1212\/NXI.0000000000000504","article-title":"Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions","volume":"5","author":"Kleiter","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R15-20260427","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archneurol.2011.216","article-title":"Failure of natalizumab to prevent relapses in neuromyelitis optica","volume":"69","author":"Kleiter","year":"2012","journal-title":"Arch Neurol"},{"key":"R16-20260427","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clineuro.2011.10.048","article-title":"Antibodies to CV2\/CRMP5 in neuromyelitis optica-like disease: Case report and review of the literature","volume":"114","author":"Jarius","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"R17-20260427","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00415-016-8138-8","article-title":"Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder","volume":"263","author":"Jeong","year":"2016","journal-title":"J Neurol"},{"key":"R18-20260427","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","article-title":"Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen","volume":"291","author":"Jarius","year":"2010","journal-title":"J Neurol Sci"},{"key":"R19-20260427","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jns.2008.06.038","article-title":"NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy","volume":"275","author":"Kay","year":"2008","journal-title":"J Neurol Sci"},{"key":"R20-20260427","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s00415-023-11634-0","article-title":"Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) \u2013 Revised recommendations of the neuromyelitis optica study group (NEMOS). Part I: Diagnosis and differential diagnosis","volume":"270","author":"Jarius","year":"2023","journal-title":"J Neurol"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_37_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:55:30Z","timestamp":1786647330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_37_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_37_24","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"2024-02-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}